Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 31;23(15):8504.
doi: 10.3390/ijms23158504.

Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides

Affiliations

Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides

Stefano Tomassi et al. Int J Mol Sci. .

Abstract

Synthetic nucleic acid interactors represent an exciting research field due to their biotechnological and potential therapeutic applications. The translation of these molecules into drugs is a long and difficult process that justifies the continuous research of new chemotypes endowed with favorable binding, pharmacokinetic and pharmacodynamic properties. In this scenario, we describe the synthesis of two sets of homo-thymine nucleopeptides, in which nucleobases are inserted in a peptide structure, to investigate the role of the underivatized amino acid residue and the distance of the nucleobase from the peptide backbone on the nucleic acid recognition process. It is worth noting that the CD spectroscopy investigation showed that two of the reported nucleopeptides, consisting of alternation of thymine functionalized L-Orn and L-Dab and L-Arg as underivatized amino acids, were able to efficiently bind DNA and RNA targets and cross both cell and nuclear membranes.

Keywords: cell penetrating peptide synthesis; cell penetrating peptides; nuclear localization sequences; nucleic acid binders; nucleopeptides.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
US-SPPS of nucleopeptides 1620.
Scheme 2
Scheme 2
US-SPPS of nucleopeptides 3135.
Figure 1
Figure 1
CD spectra of 1620 (a) and 20, 3133 (b) nucleopeptides.
Figure 2
Figure 2
CD spectra of 1620/PolyA hybrids.
Figure 3
Figure 3
CD spectra of 1620/PolydA hybrids.
Figure 4
Figure 4
CD spectra of 3133 and 20/PolyA (A) and PolydA (B) hybrids.
Figure 5
Figure 5
CD titration data of polydA and polyA, with 32 and 33, respectively.
Figure 6
Figure 6
Mean fluorescence intensity of the HT29 (a), CCRF-CEM (b) and Jurkat (c) cells containing 34 and 35 by FACS analysis (lower panel) and the representative results of FACS analysis (upper panel). CTR Neg was the fluorescence of untreated cells.

References

    1. Song J., Ren J. Recognition and regulation of unique nucleic acid structures by small molecules. Chem. Commun. 2010;46:7283–7294. doi: 10.1039/c0cc01312a. - DOI - PubMed
    1. Belmont P., Constant J.F., Demeunynck M. Nucleic acid conformation diversity: From structure to function and regulation. Chem. Soc. Rev. 2001;30:70–81. doi: 10.1039/a904630e. - DOI
    1. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433–440. doi: 10.1038/nature05919. - DOI - PubMed
    1. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011;12:861–874. doi: 10.1038/nrg3074. - DOI - PubMed
    1. Lundin K.E., Gissberg O., Smith C.I.E. Oligonucleotide Therapies: The Past and the Present. Hum. Gene Ther. 2015;26:475–485. doi: 10.1089/hum.2015.070. - DOI - PMC - PubMed

LinkOut - more resources